Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
1.650
-0.020 (-1.20%)
Nov 28, 2025, 4:00 PM EST - Market closed
Prelude Therapeutics Market Cap
Prelude Therapeutics has a market cap or net worth of $135.96 million as of November 28, 2025. Its market cap has increased by 50.59% in one year.
Market Cap
135.96M
Enterprise Value
96.38M
1-Year Change
50.59%
Ranking
Category
Stock Price
$1.65
Market Cap Chart
Since the IPO on September 25, 2020, Prelude Therapeutics's market cap has decreased from $806.64M to $135.96M, a decrease of -83.15%. That is a compound annual growth rate of -29.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 137.60M | 42.25% |
| Dec 31, 2024 | 96.73M | -70.04% |
| Dec 29, 2023 | 322.85M | 12.32% |
| Dec 30, 2022 | 287.43M | -50.22% |
| Dec 31, 2021 | 577.35M | -80.97% |
| Dec 31, 2020 | 3.03B | 276.02% |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 287.99B |
| Merck & Co. | 259.69B |
| Novartis AG | 249.49B |
| Abbott Laboratories | 223.51B |